Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05690464
NA
Effect of Magnesium Supplementation on Elevated Systolic Blood Pressure
Sponsor: Brigham and Women's Hospital
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess whether 480 mg/day magnesium glycinate supplementation for 12 weeks lowers blood pressure.
Official title: Trial of Magnesium Supplementation and Blood Pressure Reduction Among Adults With Elevated Systolic Blood Pressure
Key Details
Gender
All
Age Range
30 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-01-17
Completion Date
2026-05
Last Updated
2025-12-23
Healthy Volunteers
Yes
Conditions
Interventions
DIETARY_SUPPLEMENT
magnesium glycinate supplement
magnesium glycinate (480 mg/day)
DIETARY_SUPPLEMENT
placebo
placebo
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States